静脉推注

  • 网络Intravenous injection;intravenous bolus;IV bolus;IVP
静脉推注静脉推注
  1. 咪达唑仑持续静脉推注治疗惊厥持续状态的疗效

    Therapeutic Effect of Midazolam by Continuous Intravenous Bolus on Statural Convulsivus in Children

  2. B组,椎管内麻醉复合静脉推注咪达唑仑镇静;

    The Group B undergoing CSEA with intravenous bolus of midazolam for sedation ;

  3. C组造模后,按5mL/kg(体重)静脉推注参附注射液。

    Group C after building , according to push5mL / kg ( weight ) of intravenous inject the shenfu injection .

  4. 方法将108例因肾毒性药物所致急性肾损害患者为三组,A组36例,用前列地尔10μg,静脉推注,1次/d;

    Methods 108 patients with drug-induced acute renal damage were divided into three groups at random .

  5. Excel联合VISUALBASIC辅助制定一室模型静脉推注给药方案设计

    Dosage regimen design of multiple dosing intravenous administration of One-compartment model based on Microsoft Excel and Visual Basic

  6. B组:以依托咪酯、芬太尼诱导,静脉推注琥珀胆碱气管插管,以芬太尼静滴维持麻醉。

    Group B were induced by etomidate and fentanyl , succinylcholine intravenous blous while intubation , and maintained anesthesia by fentanyl intravenous dripped .

  7. 结论采用新癀片外敷预防持续静脉推注5-Fu所致的静脉炎效果可靠,且安全。

    Conclusions It is safe and dependable to externally use Sin-huang tablet powder to prevent phlebitis caused by persistent intravenous infusion of 5-Fu .

  8. 目的寻找预防便携式弹性输液泵持续静脉推注5-Fu致静脉炎的有效方法。

    Objective In order to search effective method to prevent phlebitis caused by persistent intravenous infusion of 5-Fu , use portable elastic transfusion pump .

  9. 新癀片外敷预防持续静脉推注5-Fu致静脉炎的临床研究

    Clinical investigation in the external use of tablet Sin - huang powder to prevent phlebitis caused by persistent infusion administration of 5 - Fu

  10. 一旦病例被选择,立即给予尿激酶200万u,(100万u静脉推注,100万u快速静脉点滴)。

    Once was chosen , The case was given UK 200 × 10 4u as soon as possible ( 100 × 10 4u intravenous injection , 100 × 10 4u intravenous transfusion ) .

  11. 增强扫描使用非离子型对比剂100ml,经肘静脉推注,速率2~3ml/s。

    Meanwhile non-ionic contrast agent was bolus injected at a speed of 2 ~ 3ml / s via cubital vein to enhance the scanning .

  12. 目的:探讨一次性静脉推注甲氨喋呤(MTX)配合中药内服、外敷保守治疗稳定型输卵管妊娠的临床应用价值。

    Objective : By injecting Methotrexate ( MTX ) and cooperating with oral administration and external treatment , to investigate the clinical value of the therapy for the stable tubal pregnancy .

  13. 2h后5-Fu500mg静脉推注;5-Fu2250mg/m2持续48h静脉泵内注入。

    Infusion , intravenous injection of 5 - Fu 500 mg 2 hours later , and then 48 - hour continuous infusion of 5 - Fu 2 250 mg / m2 using an ambulatory pump .

  14. 治疗组在对照组治疗基础上给予凯时2ml(10μg)+生理盐水10ml静脉推注,1日1次,共4周。

    The treated group was given Lipo PGE 1 2ml ( 10 μ g ) in 10 ml of normal saline by intravenation once a day and the duration of therapy was 4 weeks .

  15. 方法:(1)选用SD大鼠,静脉推注AGL总黄酮(1mg/kg,2mg/kg),观察血压波动变化。

    Methods : ( 1 ) Changes in blood pressure were observed by intravenous injections of AGL flavonoids ( 1 mg / kg , 2 mg / kg ) in rats .

  16. 氨力农组30例,以氨力农注射液50mg加于0.9%氯化钠注射液20mL中静脉推注,再以150mg加于0.9%氯化钠注射液250mL中静滴2h,qd,共14d。

    Thirty patients of amrinone group , amrinone 50 mg in 0.9 % sodium chloride 250 mL were used for intravenous infusion in 2 h , qd , for 14 d.

  17. 结果大剂量表阿霉素组(90mg/m2缓慢静脉推注)优于常规剂量组(50mg/m2)。

    RESULTS The effect of high dose epirubicin ( 90 ? mg / m 2 iv slow ) was superior to that of regular dose epirubicin ( 50 ? mg / m 2 ) .

  18. 区域性动脉灌注组胰腺组织中5-FU的Cmax为20.00ug/g,存留时间为90min,皆明显高于静脉推注组(P<0.05)。

    In the regional arterial infusion group , Cmax of 5-FU in the pancreas was 20 . 00 ug / gand the clearance time of the pancreas was 90 min. They were both greater than those of the intravenous group .

  19. 方法:根据反向累加生成GOM(1,1)的建模原理,给出快速静脉推注药物动力学的灰色模型。

    Methods : Based on the theory of accumulated generating opposite-direction GOM ( 1,1 ) of the set-up model , the grey pharmacokinetics model of fleetness intravenous infusion was made .

  20. 目的:观察注射用纳米羟喜树碱(HCPT纳米针剂)静脉推注后小鼠体内组织分布情况,并与注射用羟喜树碱(HCPT针剂)比较组织分布特征。

    AIM : To investigate the tissue distribution performance of 10-hydroxycamptothecin ( HCPT ) nanoparticle injection in mice and those of HCPT nanoparticle injection 's peculiar tissue distribu-tion transformation in mice by comparing with control substance & HCPT common injection .

  21. 方法:呼吸道绿脓杆菌感染52例(男33例,女19例,年龄61.2±4.5岁),以氨曲南4~8g·d-1,静脉推注,疗程12.5±2.5d。

    METHODS : Fifty-two patients with respiratory pyocyanic infections ( M33 . F19 ; age 61.2 ± 4.5 a ), received aztreonam for injection 4  ̄ 8 g · d - 1 iv for 12.5 ± 2.5 d.

  22. 本文报告在迈瑞PC2000型监护仪监测下,使用美国道奇静脉推注泵在163例假体隆胸手术中施行靶控静脉复合麻醉的应用。

    This paper had reported the application of venous complex anesthesia with target control during 163 cases of humping breast under PC 2000 monitor injected with pump .

  23. 方法:随机选取38例恶性血液病患者,于化疗前15分钟静脉推注奈西雅0.3mg或5μg/kg,每日1次。

    Methods : A repeated dose of Nasea at 0.3 mg or 5 μ g / kg once daily was intravenously administered 15 minutes prior to combined daily chemotherapy to patient with malignant blood diseases .

  24. 对135例心力衰竭的高龄患者,通过微量输液泵静脉推注硝普钠、多巴胺、多巴酚丁胺,根据血压、心率、心功能等调节输液速度,连续使用7~20d获得满意疗效。

    Advanced-age heart failure patients were continuously treated for 7 ~ 20 days by combined intravenous infusion of dopamine , dobutamine and sodium nitroprusside , achieving satisfactory therapeutic effects by adjusting the drip velocity according to blood pressure , heart rate and heart function .

  25. 方法:采用在化疗前、后预防性使用2%利多卡因5ml加地塞米松2.5mg静脉推注,以减轻药物对局部组织的不良反应并与化疗前、后不使用任何药物进行比较。

    Methods : In order to reduce the local toxic reaction , 2 % lidocaine 5 ml and dexamethasone 2.5 mg were used in the research group before and after chemotherapy , and compared with the control group only with chemotherapy .

  26. 小密封瓶滴注替代静脉推注给药效果观察氨溴索静脉给药佐治毛细支气管炎疗效观察

    Clinical Efficacy of Intravenous Drip in Small Transfusion Bottle Replacing Intravenous Injection

  27. 经脐静脉推注催产素防止胎盘嵌顿的临床探讨

    Clinical probe of injecting oxytocin through umbilical vein to prevent incarcerated placenta

  28. 静脉推注药物时小人啼哭致窒息3例

    Young Children with Asphyxia Caused by Cry during Intravenous Injection

  29. 大剂量静脉推注纳络酮十分安全。

    Intravenous large doses naloxone is safety in the course of treatment .

  30. 静脉推注药液不溶性微粒污染的实验分析

    Pollution Analysis of Insoluble Fine Particle in Intravenous Injection Liquids